These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 16595584)

  • 1. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.
    ; Stewart JH; McCredie MR; Williams SM
    Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.
    Stewart JH; McCredie MR; Williams SM; Jager KJ; Trpeski L; McDonald SP;
    Nephrology (Carlton); 2007 Oct; 12(5):520-7. PubMed ID: 17803478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002.
    ; Stewart JH; McCredie MR; Williams SM
    Diabet Med; 2006 Dec; 23(12):1364-9. PubMed ID: 17116189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of end-stage renal disease in overseas-born, compared with Australian-born, non-indigenous Australians.
    Stewart JH; McCredie MR; McDonald SP
    Nephrology (Carlton); 2004 Aug; 9(4):247-52. PubMed ID: 15363057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
    Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
    Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia.
    Stewart JH; McCredie MR; Williams SM; McDonald SP
    Nephrology (Carlton); 2004 Aug; 9(4):238-46. PubMed ID: 15363056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades.
    Cao C; Hellermann JP; Weber M; Ambühl PM
    Nephrol Dial Transplant; 2006 Mar; 21(3):770-5. PubMed ID: 16401627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
    Villar E; Chang SH; McDonald SP
    Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy.
    Grace BS; Clayton P; McDonald SP
    Nephrology (Carlton); 2012 Jan; 17(1):76-84. PubMed ID: 21854505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in incidence of end-stage renal failure in Australia, 1972-1991.
    Stewart JH; McCredie M; Disney AP; Mathew TH
    Nephrol Dial Transplant; 1994; 9(10):1377-82. PubMed ID: 7816248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk.
    Lorenzo V; Boronat M; Saavedra P; Rufino M; Maceira B; Novoa FJ; Torres A
    Nephrol Dial Transplant; 2010 Jul; 25(7):2283-8. PubMed ID: 20064954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic CKD/ESRD 2010: a progress report?
    Williams ME
    Semin Dial; 2010; 23(2):129-33. PubMed ID: 20210917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.
    Kramer A; Stel V; Zoccali C; Heaf J; Ansell D; Grönhagen-Riska C; Leivestad T; Simpson K; Pálsson R; Postorino M; Jager K;
    Nephrol Dial Transplant; 2009 Dec; 24(12):3557-66. PubMed ID: 19820003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional and social inequalities in chronic renal replacement therapy in Denmark.
    Hommel K; Rasmussen S; Kamper AL; Madsen M
    Nephrol Dial Transplant; 2010 Aug; 25(8):2624-32. PubMed ID: 20207710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic end-stage renal disease in the indigenous population of the Commonwealth of the Northern Mariana Islands.
    Abidi SM; Negrete HO; Zahid I; Bennett PH; Nelson RG
    Nephrology (Carlton); 2005 Jun; 10(3):291-5. PubMed ID: 15958044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and prevalent patients with end-stage renal disease in Canada. A portrait of the year 2000.
    Desmeules M; Schaubel D; Fenton SS; Mao Y
    ASAIO J; 1995; 41(2):230-3. PubMed ID: 7640434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of end-stage renal disease in Georgia.
    McClellan W; Brogan D
    J Med Assoc Ga; 1990 Mar; 79(3):153-6. PubMed ID: 2319217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-stage renal disease due to diabetes in racial/ethnic minorities and disadvantaged populations.
    Lopes AA
    Ethn Dis; 2009; 19(1 Suppl 1):S1-47-51. PubMed ID: 19484875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.